[Federal Register Volume 62, Number 115 (Monday, June 16, 1997)]
[Pages 32625-32626]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-15742]



National Institutes of Health

National Heart, Lung, and Blood Institute; Notice of Closed 

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 

[[Page 32626]]

Lung, and Blood Special Emphasis Panel (SEP) meetings:

    Name of SEP: Host Factors Controlling Individual Susceptibility 
to HIV-Associated Pulmonary Disease.
    Date: July 9, 1997.
    Time: 8:00 a.m.
    Place: Holiday Inn Chevy Chase, 5520 Wisconsin Avenue, Chevy 
Chase, Maryland 20815.
    Contact Person: Anne Clark, Ph.D., Two Rockledge Center, Room 
7186, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-0280.
    Purpose/Agenda: To review and evaluate grant applications.

    Name of SEP: Gene Transfer Principles for Heart, Lung, and Blood 
    Date: July 9-11, 1997.
    Time: 7:30 p.m.
    Place: Doubletree Hotel Rockville, 1750 Rockville Pike, 
Rockville, Maryland 20852.
    Contact Person: Ivan Baines, Ph. D., Two Rockledge Center, Room 
7184, 6701 Rockledge Drive, Bethesda, MD 20892-7924, (301) 435-0277.
    Purpose/Agenda: To review and evaluate grant applications.

    These meetings will be closed in accordance with the provisions 
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
93.839, Blood Diseases and Resources Research, National Institutes 
of Health)

    Dated: June 10, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-15742 Filed 6-13-97; 8:45 am]